Search results
Scientists reveal why American man with prostate cancer developed ‘uncontrolled’ Irish accent
The Independent via Yahoo News· 1 year agoAn American man developed an “uncontrollable” Irish brogue after his prostate cancer surgery despite...
Merck scraps Keytruda trial for prostate cancer after dismal interim data
Reuters via Yahoo News· 1 year agoThe interim analysis showed the therapy did not extend survival or help extend the time a patient...
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
Benzinga via Yahoo Finance· 1 year agoAstellas Pharma Inc (OTC: ALPMY) and Pfizer Inc (NYSE: PFE) announced detailed Phase 3 EMBARK trial...
Getting Too Much Bright Light at Night May Increase Your Cancer Risks. Here's Why
Verywell Health via Yahoo News· 4 months agoResearch shows that exposure to bright lights at night—especially blue light—increases the risk of...
FDA Approves Expanded Use For Bayer's Prostate Cancer Drug
Benzinga via Yahoo Finance· 2 years agoThe FDA approved Bayer AG's (OTC: BAYRY) supplemental marketing application for Nubeqa...
EastEnders has an important opportunity for change with Alfie's storyline
Digital Spy via Yahoo News· 4 months agoEastEnders spoilers follow. One of EastEnders’ most important ongoing storylines at the moment is...
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
Zacks via Yahoo Finance· 1 year agoThis week, J&J JNJ began the fourth-quarter earnings season for the drug and biotech sector with...
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
Benzinga via Yahoo Finance· 1 year agohttps://cdn.benzinga.com/files/images/story/2023/03/17/pfe.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Pfizer Inc (NYSE: PFE) and Astellas Pharma Inc (OTC: ALPMY) released topline results ...
Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy
Zacks via Yahoo Finance· 6 months agoSwiss pharma giant Novartis NVS raised its sales and operating income goals for the mid-term, post...
Novartis' (NVS) Pluvicto Secures Positive CHMP Opinion
Zacks via Yahoo Finance· 2 years agoNovartis (NVS) radioligand therapy Pluvicto gets positive recommendation by the CHMP for patients...